| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |